Iradimed Corp. (IRMD) Tops Q3 EPS by 3c

Go back to Iradimed Corp. (IRMD) Tops Q3 EPS by 3c

IRADIMED CORPORATION Announces Third Quarter 2015 Financial Results

October 30, 2015 7:30 AM EDT

Revenue grows 114.9% compared to the same quarter last yearReports third quarter 2015 non-GAAP diluted EPS of $0.19Increases annual revenue and non-GAAP earnings guidance

WINTER SPRINGS, Fla., Oct. 30, 2015 (GLOBE NEWSWIRE) -- iRadimed Corporation (NASDAQ: IRMD), the only known provider of non-magnetic intravenous (IV) infusion pump systems that are designed to be safe for use during magnetic resonance imaging (MRI) procedures, today announced financial results for the three months ended September 30, 2015. 

For the third quarter ended September 30, 2015, the Company reported revenue of $8.2 million, an increase of 114.9% compared to $3.8 million for... More

IRADIMED CORPORATION Announces Dismissal of Appeal

October 30, 2015 7:30 AM EDT

WINTER SPRINGS, Fla., Oct. 30, 2015 (GLOBE NEWSWIRE) -- iRadimed Corporation (NASDAQ: IRMD), the only known provider of non-magnetic intravenous (IV) infusion pump systems that are designed to be safe for use during magnetic resonance imaging (MRI) procedures, announced today that with regards to the Lam Civil Action matter, the U.S. Court of Appeals for the Eleventh Circuit, on joint motion of... More